760 related articles for article (PubMed ID: 25277423)
1. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
Basire A; Picard C
Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
[TBL] [Abstract][Full Text] [Related]
2. [Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM].
Dettori I; Ladaique P
Transfus Clin Biol; 2014 Nov; 21(4-5):207-9. PubMed ID: 25267204
[TBL] [Abstract][Full Text] [Related]
3. Identification of anti-HPA-1a allo-antibodies using IgG platelet antibody detection and crossmatch system assay with Galileo Echo.
Di Cristofaro J; Frassati C; Montagnie R; Basire A; Merieux Y; Picard C
Platelets; 2015; 26(5):421-4. PubMed ID: 25101933
[TBL] [Abstract][Full Text] [Related]
4. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
[TBL] [Abstract][Full Text] [Related]
6. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
[TBL] [Abstract][Full Text] [Related]
7. Use of HLA- and HPA--matched platelets in alloimmunized patients.
Kekomäki R
Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468
[TBL] [Abstract][Full Text] [Related]
8. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
9. [Caracterization of HLA allo-immunization and clinical impact in transfusion and organ transplantation].
Delbos F; Cesbron A
Transfus Clin Biol; 2017 Sep; 24(3):131-137. PubMed ID: 28757117
[TBL] [Abstract][Full Text] [Related]
10. The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness.
Beligaswatte A; Tsiopelas E; Humphreys I; Bennett G; Robinson K; Davis K; Bardy P
Br J Haematol; 2013 Aug; 162(3):409-12. PubMed ID: 23651440
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
Fagundes IS; Franz JM; Jobim MS; Arend A; Merzoni J; Cardone JM; Gil B; Sekine L; Jobim LF
Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
[TBL] [Abstract][Full Text] [Related]
12. Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation.
Rozman P
Transpl Immunol; 2002 Aug; 10(2-3):165-81. PubMed ID: 12216947
[TBL] [Abstract][Full Text] [Related]
13. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a.
Boehlen F; Kaplan C; de Moerloose P
Vox Sang; 1998; 74(3):201-4. PubMed ID: 9595650
[TBL] [Abstract][Full Text] [Related]
14. Platelet transfusion refractoriness.
Hod E; Schwartz J
Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
[TBL] [Abstract][Full Text] [Related]
15. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
Saris A; Pavenski K
Transfus Med Rev; 2020 Oct; 34(4):250-257. PubMed ID: 33127210
[TBL] [Abstract][Full Text] [Related]
16. The detection of platelet antibodies by simultaneous analysis of specific platelet antibodies and the monoclonal antibody-specific immobilization of platelet antigens: an interlaboratory comparison.
Nguyen XD; Goebel M; Schober M; Klüter H; Panzer S
Transfusion; 2010 Jul; 50(7):1429-34. PubMed ID: 20456677
[TBL] [Abstract][Full Text] [Related]
17. [Platelet antigens, antibodies and related clinical conditions].
Muñiz Díaz E
Sangre (Barc); 1991 Oct; 36(5):395-415. PubMed ID: 1840085
[No Abstract] [Full Text] [Related]
18. Novel method for simultaneously detecting HPA and HLA antibodies using Luminex microbeads.
Tao S; Chen S; Hong X; He J; Zhu F
J Transl Med; 2019 Aug; 17(1):249. PubMed ID: 31382976
[TBL] [Abstract][Full Text] [Related]
19. Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haematologic-oncologic patients.
Schnaidt M; Northoff H; Wernet D
Transfus Med; 1996 Jun; 6(2):111-4. PubMed ID: 8809957
[TBL] [Abstract][Full Text] [Related]
20. [Fetal/neonatal allo-immune thrombocytopenias: the unsolved questions].
Kaplan C
Transfus Clin Biol; 2005 Jun; 12(2):131-4. PubMed ID: 15950890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
